EuroMAbNet: European Monoclonal Antibodies NetworkEuroMAbNet. European Monoclonal Antibodies Network

Antibody Validation Webinar Series

Antibody Validation Webinar Series

STARTING NOVEMBER 12th, 2019-2020

Tool antibodies are the dominant affinity reagent for proteomics in cell biology, reflected by the over 4.5 million antibodies that are commercially available. Distinct from therapeutics or diagnostics, tool antibodies tend to be poorly characterized. This is echoed by many reports of catastrophic specificity, activity, identity and reporting deficits involving such reagents.

In this 9-part series, aimed especially at those beginning a career in biological sciences, The Antibody Society has invited leaders in antibody research from industry and academia to reflect on antibody validation. They paint a uniformly alarming picture of inadequacies at many levels – which encourages users to be highly aware of the consequences of inadequate tool antibody validation, which threaten their biological endeavors.

Do not miss this opportunity. Learn how to validate antibodies

The European antibody network's practical guide to finding and validating suitable Abs for research

Are you interested in learn how to validate your antibody?

EuroMAbNet has published an article and created easily followed "Guidelines" that provide a set of criteria and recommendations that will help you to select the most effective mAbs from those available in the market and provide the strategic guidance needed to perform any essential antibody validation.

The first European network

EuroMAbNet represents the first European network of laboratories linked to academic Institutions, each having an internationally recognized reputation in the production and use of monoclonal antibodies.

Exchange of knowledge

EuroMAbNet provide an arena in which people working in the field of monoclonal antibody production and technology can exchange knowledge, share the most up-to-date methodology and create common strategies to both standardize and improve the production of properly validated monoclonal antibodies.

Antibody validation article and guidelines

EuroMAbNet has recently published a position paper, and Ab validation guidelines providing criteria and recommendations aimed at helping researchers to select the most effective mAbs from those available in the market, and the guidance needed to perform effective antibody validation.